International Publisher of Science, Technology and Medicine

 

Anand Rohatgi

Anand Rohatgi

Anand Rohatgi, MD
Department of Internal Medicine
University of Texas Southwestern Medical Center, USA

 

Biography

General cardiologist Anand Rohatgi, M.D., M.S.C.S., F.A.C.C., F.A.H.A., is an Assistant Professor of Medicine in the Department of Internal Medicine’s Division of Cardiology at UT Southwestern Medical Center. He specializes in preventive cardiology. Dr. Rohatgi earned his medical degree from the Duke University School of Medicine before completing an internal medicine residency at the University of Pennsylvania Health System and a cardiology fellowship at UT Southwestern. He also holds a master’s degree in clinical science from UT Southwestern’s Department of Clinical Sciences. He joined the UT Southwestern faculty in 2008. In addition to his clinical roles, Dr. Rohatgi serves as Director of both echocardiography course education and Internal Medicine’s cardiology didactic curriculum. He is also a member of Internal Medicine’s Committee to Evaluate Clinical Competence. He is an active CME speaker and has given several invited national talks. Dr. Rohatgi’s research focuses on the role of novel biomarkers in improving risk prediction for atherosclerosis and coronary artery disease. Specifically, his main area of interest is the role of high-density lipoproteins (HDL) in cardiovascular disease. He is currently the principal investigator of “Moving Beyond HDL Cholesterol: HDL Function as a Coronary Disease Biomarker,” a five-year study funded by the National Institute of Health (NIH) career development award (K08), the American Heart Association Scientist Development Grant, and the Merck Investigator Studies Program, as well as the lead site investigator of the Eli Lilly-sponsored ACCELERATE study to evaluate the drug evacetrapib in patients with high cardiovascular risk. Dr. Rohatgi is American Board of Internal Medicine-certified in cardiovascular disease and internal medicine. He serves as a reviewer for a number of publications, including The Lancet, Journal of the American Medical Association, Journal of the American Heart Association, American Journal of Cardiology, and Arteriosclerosis, Thrombosis, and Vascular Biology. He is an Associate Editor of the American College of Cardiology Cardiosource Biomarker Community. A Fellow of both the American College of Cardiology and the American Heart Association, Dr. Rohatgi is a member of professional organizations that include the American College of Physicians and the National Lipid Association. He also chairs the board of directors of the nonprofit Texas Loves Children.

Research Interest

Dr. Rohatgi research interests include Biomarkers for Atherosclerosis and Coronary Artery Disease, High-density Lipoprotein, Inflammation and Atherosclerosis

izmit escort sex geschichten escort bayan porno sikis adult porno pornolar
test